Cargando…
Use of Belatacept as Alternative Immunosuppression in Three Renal Transplant Patients with De Novo Drug-Induced Thrombotic Microangiopathy
Thrombotic microangiopathy (TMA), a severe complication of renal transplantation, is a pathological process involving microvascular occlusion, thrombocytopenia, and microangiopathic hemolytic anemia. It generally appears within the first weeks after transplantation, when immunosuppressive drugs are...
Autores principales: | Cicora, Federico, Paz, Marta, Mos, Fernando, Roberti, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806345/ https://www.ncbi.nlm.nih.gov/pubmed/24198835 http://dx.doi.org/10.1155/2013/260254 |
Ejemplares similares
-
Optimization of de novo belatacept‐based immunosuppression administered to renal transplant recipients
por: Kirk, Allan D., et al.
Publicado: (2020) -
Belatacept for Maintenance Immunosuppression in Lung Transplantation
por: Hui, Christine, et al.
Publicado: (2014) -
Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
por: Peddi, V. Ram, et al.
Publicado: (2023) -
Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease
por: Abbas, Fedaey, et al.
Publicado: (2018) -
Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)